Koers Prevail Therapeutics Inc.
Aandelen
PRVL
US74140Y1010
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 01-03-18 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-03-18 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 01-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,17% | 104 mld. | |
+2,87% | 97,47 mld. | |
+4,13% | 22,25 mld. | |
-14,77% | 21,68 mld. | |
-8,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-13,21% | 16,36 mld. | |
+8,55% | 14,39 mld. | |
+35,75% | 12,37 mld. |